Clinical Research Details
Title:
A Study Comparing the Combination of Azacitidine With Entinostat for the Treatment of Myelodysplastic Syndrome, Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia
Purpose:
The purpose of this study is to determine the safety and effectiveness of combining azacitidine with entinostat for myelodysplastic syndrome, chronic myelomonocytic leukemia and acute myeloid leukemia.
Study Number:
202589031710
Number of Patients:
196
Elgibility:
You may be eligible if you are 18 years of age or older and have been diagnosed with either myelodysplastic syndrome, chronic myelomonocytic leukemia or acute myeloid leukemia with multilineage dysplasia.
Treatment:
Participants will be placed in one of two groups: azacitidine or azacitidine plus entinostat.
Principal Investigator:
Enrollment Phone:
(708) 327-3142